![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/20/2901534/0/en/Spur-Therapeutics-to-Participate-in-the-H-C-Wainwright-5th-Annual-Neuro-Perspectives-Virtual-Conference.html
https://www.globenewswire.com/news-release/2024/06/17/2899496/0/en/Spur-Therapeutics-Formerly-Freeline-Announces-New-Name-and-Brand.html
https://www.contractpharma.com/contents/view_breaking-news/2024-06-17/freeline-therapeutics-rebrands-to-spur-therapeutics/?widget=listSection
https://www.globenewswire.com/news-release/2024/05/09/2878510/0/en/Freeline-Presents-Positive-New-Data-from-Phase-1-2-Trial-of-FLT201-Its-Novel-Gene-Therapy-Candidate-for-Gaucher-Disease-in-Late-Breaking-Oral-Presentation-at-ASGCT-27th-Annual-Meet.html
https://www.globenewswire.com/news-release/2024/04/24/2869032/0/en/Freeline-to-Present-New-Data-on-its-Gaucher-and-Parkinson-s-Disease-Programs-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-27th-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/20/2831678/0/en/Acquisition-of-Freeline-by-Syncona-Becomes-Effective.html
https://www.globenewswire.com//news-release/2024/02/12/2827728/0/en/Freeline-Shareholders-Approve-Acquisition-by-Syncona.html
https://www.fiercebiotech.com/biotech/investment-firm-syncona-throws-lifeline-freeline-buying-out-struggling-biotech
https://www.globenewswire.com//news-release/2023/11/22/2784727/0/en/Syncona-to-Acquire-Freeline-Therapeutics.html
https://www.globenewswire.com//news-release/2023/10/25/2766204/0/en/Freeline-Presents-Positive-New-Data-from-Phase-1-2-GALILEO-1-Trial-of-FLT201-Its-Novel-Gene-Therapy-Candidate-in-Gaucher-Disease-at-ESGCT-30th-Annual-Congress.html